CLINICAL_TRIALS
trial_result
· 2018-02-15
Clinical Trial Update: Behavioural Addictions Occurring During a Dopaminergic Treatment Prescribe Under Parkinson's Disease: Study of the Psychopathological, Neurological, Pharmacokinetic and Genetic Profiles [Phase 4]
Summary
Phase 4 trial investigating behavioural addictions that occur during dopaminergic therapy in Parkinson's disease, examining psychopathological, neurological, ph…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Nantes University Hospital | Conditions: Parkinson's Disease, Secondary Behavioural Addiction | Phase 4 | Status: COMPLETED